Grupo Ferrer Internacional SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company's history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company's key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.
Scope
- Business description - A detailed description of the company's operations and business divisions.
- Corporate strategy - The publisher's summarization of the company's business strategy.
- SWOT analysis - A detailed analysis of the company's strengths, weakness, opportunities and threats.
- Company history - Progression of key events associated with the company.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Executive biographies - A brief summary of the executives' employment history.
- Key operational heads - A list of personnel heading key departments/functions.
- Important locations and subsidiaries - A list of key locations and subsidiaries of the company, including contact details.
Highlights
Grupo Ferrer Internacional SA (Ferrer) manufactures and markets pharmaceuticals and chemicals products. The company offers its products for various therapeutic areas including cardiovascular, central nervous system, oncology, dermatology, gastrointestinal, phlebology, musculoskeletal system, pain, paediatrics and the respiratory system. It also provides over-the-counter medicines, dermo-cosmetics, food supplements, cough syrups and expectorants, anti-lice and insect repellent products, infant nutrition products, and other skincare products. Ferrer offers its products under Nucleo, Keltican, Nubit, Somazina, Ceraxon, Zynapse, Hidrasec, Tiorfan, Gelocatil, Abfentiq, and Kaptic brand names. The company also offers diagnostics services through its subsidiary Ferrer inCode. The company operates production facilities in Spain and the US. Ferrer is headquartered in Barcelona, Spain.Grupo Ferrer Internacional SA Key Recent Developments
- Feb 22, 2023: Ferrer signs licence deal with Asceneuron for ASN90 to treat PSP
- May 27, 2022: Ferrer, participante del B Good Day de B Lab Spain
Reasons to Buy
- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report's analysis of the company's business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors' business structure and strategies with the publisher's detailed SWOT analysis. In this, the company's core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report's detailed insight into the company's strategic, business and operational performance.
Table of Contents
Section 1 - About the Company- Grupo Ferrer Internacional SA - Key Facts
- Grupo Ferrer Internacional SA - Key Employees
- Grupo Ferrer Internacional SA - Key Employee Biographies
- Grupo Ferrer Internacional SA - Major Products and Services
- Grupo Ferrer Internacional SA - History
- Grupo Ferrer Internacional SA - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Company Overview
- Grupo Ferrer Internacional SA - Business Description
- R&D Overview
- Grupo Ferrer Internacional SA - Corporate Strategy
- Grupo Ferrer Internacional SA - SWOT Analysis
- SWOT Analysis - Overview
- Grupo Ferrer Internacional SA - Strengths
- Grupo Ferrer Internacional SA - Weaknesses
- Grupo Ferrer Internacional SA - Opportunities
- Grupo Ferrer Internacional SA - Threats
- Grupo Ferrer Internacional SA - Key Competitors
- Grupo Ferrer Internacional SA, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023
- Grupo Ferrer Internacional SA, Pharmaceuticals & Healthcare, Deals By Type, 2017 to YTD 2023
- Grupo Ferrer Internacional SA, Recent Deals Summary
- Feb 22, 2023: Ferrer signs licence deal with Asceneuron for ASN90 to treat PSP
- May 27, 2022: Ferrer, participante del B Good Day de B Lab Spain
- Methodology
- About the Publisher
- Contact the Publisher
- Disclaimer
- Grupo Ferrer Internacional SA, Key Facts
- Grupo Ferrer Internacional SA, Key Employees
- Grupo Ferrer Internacional SA, Key Employee Biographies
- Grupo Ferrer Internacional SA, Major Products and Services
- Grupo Ferrer Internacional SA, History
- Grupo Ferrer Internacional SA, Other Locations
- Grupo Ferrer Internacional SA, Subsidiaries
- Grupo Ferrer Internacional SA, Key Competitors
- Grupo Ferrer Internacional SA, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023
- Grupo Ferrer Internacional SA, Pharmaceuticals & Healthcare, Deals By Type, 2017 to YTD 2023
- Grupo Ferrer Internacional SA, Recent Deals Summary
- Grupo Ferrer Internacional SA, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023
- Grupo Ferrer Internacional SA, Pharmaceuticals & Healthcare, Deals by Type, 2017 to YTD 2023
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Zentiva Group AS
- AstraZeneca Plc
- Grunenthal Pharma SA
- neuraxpharm Arzneimittel GmbH
- Novartis AG
